Straub, Rachel K, Powers, Christopher M · Healthcare (Basel, Switzerland) · 2021 · DOI
This study follows one patient's journey with severe ME/CFS, examining how past infections and health conditions may have contributed to her illness and how various treatments affected her recovery. The case highlights that some treatments can paradoxically make symptoms worse before improvement occurs, especially if someone has high levels of lingering infections. The patient eventually improved enough to return to graduate school, though her experience also shows how serious and disabling ME/CFS can be for some people.
This case report addresses the severe end of the ME/CFS disease spectrum and documents real-world treatment experiences, which is important given the lack of FDA-approved treatments and the devastating functional impact on some patients. It highlights the complex relationship between infections, treatment initiation, and paradoxical symptom worsening—a phenomenon that clinicians and patients should understand when considering interventions. The detailed documentation of one patient's path to partial recovery may provide insights for clinical management in severe cases.
This single case report cannot prove that any particular treatment caused the patient's improvement, as multiple interventions were used simultaneously and natural disease fluctuation cannot be ruled out. It does not establish the prevalence or incidence of Jarisch-Herxheimer reactions in ME/CFS patients, nor does it demonstrate that the identified comorbidities caused the ME/CFS development. The findings cannot be generalized to the broader ME/CFS population, as this represents only one patient's experience.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Straub, Rachel K & Powers, Christopher M (2021). Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch-Herxheimer Reactions If High Infectious Loads Are Present.. Healthcare (Basel, Switzerland). https://doi.org/10.3390/healthcare9111537
BibTeX
@article{mecfsatlas-straub-2021-chronic-fatigue,
author = {Straub, Rachel K and Powers, Christopher M},
title = {Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch-Herxheimer Reactions If High Infectious Loads Are Present.},
journal = {Healthcare (Basel, Switzerland)},
year = {2021},
doi = {10.3390/healthcare9111537},
note = {PubMed: 34828583},
url = {https://www.mecfsatlas.com/evidence/straub-2021-chronic-fatigue},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-26. https://www.mecfsatlas.com/evidence/straub-2021-chronic-fatigue
Contribute
Private, reviewed by a human. Not a public comment thread.